KOSDAQ pharmas superior to KOSPI ones in SG&A expenses growth rate
Last year, KOSDAQ listed pharmaceutical companies had a higher increase of SG&A(selling, general and administrative) expenses than the KOSPI listed pharmaceutical companies’ increase on average. In the 4th quarter after the Kim Young-Ran Law was enforced, the company in the KOSPI recorded a negat...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
